Paul Aisen, MD - Alzheimer's Clinical Trials Consortium

Founding Director, Alzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California

Advancing Alzheimer's Disease Therapies in a Collaborative Science Ecosystem (Section 1) - Alzheimer's Disease Drug Development

Investigational Anti-amyloid Treatment Started Before Alzheimer's Symptoms Did Not Slow Memory Loss - Neuroscience News

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

Detect Alzheimer's disease before memory loss

Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease, Alzheimer's Research & Therapy

UCSD vs. USC, Paul Aisen, Et Al., PDF, Clinical Trial

Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future - IOS Press

RE-ENGINEERING ALZHEIMER CLINICAL TRIALS: GLOBAL ALZHEIMER'S PLATFORM NETWORK • The Journal of Prevention of Alzheimer's Disease